Daniel Flicker, PhD

Senior Associate

---

Daniel Flicker joined the T1D Fund in January 2025. Prior to joining the Fund, he was a Senior Associate at Novo Holdings, where he focused on venture investments across biotech and medtech company stages and therapeutic areas, and served as a board observer for three portfolio companies.

Earlier in his career, Daniel worked in healthcare investment banking and equity research at Chardan, and in life sciences management consulting at L.E.K. Consulting.

Daniel earned his Ph.D. in Systems Biology from Harvard University, where his research focused on mitochondrial metabolism in brown fat. He holds a B.A. in Biochemistry from Columbia University.